Many ways to make an influenza virus - review of influenza virus reverse genetics methods

Influenza and other Respiratory Viruses

Volumn 7, Issue 3, 2013, Pages 249-256

  Engelhardt, Othmar G ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Candidate vaccine viruses; Influenza virus; Methods; Reverse genetics

Indexed keywords

ARTICLE; GENE MUTATION; GENE TARGETING; GENOTYPE; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; RNA VIRUS; VIRAL GENETICS;

ANIMALS; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; REVERSE GENETICS;

EID: 84876484273     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00392.x     Document Type: Article

References (63)

1. Green KY. The noroviruses; in Knipe DM, Howley PM (eds): Fields Virology, 5th edn. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2007; 949-979.
2. Dong J, Matsuoka Y, Maines TR et al. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respi Viruses 2009; 3:287-295.
3. Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 2005; 22:2943-2952.
4. Robertson JS, Engelhardt OG. Developing vaccines to combat pandemic influenza. Viruses [Review] 2010; 2:532-546.
5. Wood JS, Robertson JS. Reference viruses for seasonal and pandemic influenza vaccine preparation. Influenza Other Respi Viruses 2007; 1:5-9.
6. Enami M, Luytjes W, Krystal M, Palese P. Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A 1990; 87:3802-3805.
7. Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 1989; 59:1107-1113.
8. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol 1999; 73:9679-9682.
9. Neumann G, Watanabe T, Ito H et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 1999; 96:9345-9350.
10. Neumann G, Kawaoka Y. Generation of influenza A virus from cloned cDNAs--historical perspective and outlook for the new millenium. Rev Med Virol 2002; 12:13-30.
11. Neumann G, Kawaoka Y. Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. Curr Top Microbiol Immunol 2004; 283:43-60.
12. Enami M, Palese P. High-efficiency formation of influenza virus transfectants. J Virol 1991; 65:2711-2713.
13. Parvin JD, Palese P, Honda A, Ishihama A, Krystal M. Promoter analysis of influenza virus RNA polymerase. J Virol 1989; 63:5142-5152.
14. Seong BL, Brownlee GG. A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo. Virology 1992; 186:247-260.
15. Shaw MW, Kiseleva IV, Egorov AY, Hemphill ML, Xu X. Generation of influenza transfectants using purified recombinant nucleocapsid protein. J Virol Methods 1998; 76:149-151.
16. Neumann G, Zobel A, Hobom G. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology 1994; 202:477-479.
17. Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol 1996; 70:4188-4192.
18. Zobel A, Neumann G, Hobom G. RNA polymerase I catalysed transcription of insert viral cDNA. Nucleic Acids Res 1993; 21:3607-3614.
19. Muster T, Egorov A, inventors; AVIR Green Hills Biotechnology Research Development Trade AG Vienna Austria, assignee. Novel method for generation of RNA virus. US patent application 20100184191. US. 2010.
20. Poomputsa K, Kittel C, Egorov A, Ernst W, Grabherr R. Generation of recombinant influenza virus using baculovirus delivery vector. J Virol Methods 2003; 110:111-114.
21. Enami M, Enami K. Characterization of influenza virus NS1 protein by using a novel helper-virus-free reverse genetic system. J Virol 2000; 74:5556-5561.
22. Wagner E, Engelhardt OG, Gruber S, Haller O, Kochs G. Rescue of recombinant Thogoto virus from cloned cDNA. J Virol 2001; 75:9282-9286.
23. Heix J, Grummt I. Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev 1995; 5:652-656.
24. Paule MR, White RJ. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res 2000; 28:1283-1298.
25. Koudstaal W, Hartgroves L, Havenga M et al. Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. Vaccine 2009; 27:2588-2593.
26. Hoffmann E, Webster RG. Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. J Gen Virol 2000; 81(Pt 12):2843-2847.
27. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 2000; 97:6108-6113.
28. Schickli JH, Flandorfer A, Nakaya T, Martinez-Sobrido L, Garcia-Sastre A, Palese P. Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci 2001; 356:1965-1973.
29. Legastelois I, Garcia-Sastre A, Palese P et al. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respi Viruses 2007; 1:95-104.
30. Suphaphiphat P, Keiner B, Trusheim H et al. Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. J Virol 2010; 84:3721-3725.
31. Murakami S, Horimoto T, Yamada S, Kakugawa S, Goto H, Kawaoka Y. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol 2008; 82:1605-1609.
32. Wang Z, Duke GM. Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol J 2007; 4:102.
33. Massin P, Rodrigues P, Marasescu M, van derWerf S, Naffakh N. Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol 2005; 79:13811-13816.
34. Zhang X, Kong W, Ashraf S, Curtiss R III. A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol 2009; 83:9296-9303.
35. de Wit E, Spronken MI, Vervaet G, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol 2007; 88(Pt 4):1281-1287.
36. Kawaoka Y, Hamm S, Ebihara H, inventors; Wisconsin Alumni Research Foundation (Madison, WI), assignee. Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy. US patent 7, 723, 094. US. 2010.
37. Jackson D, Cadman A, Zurcher T, Barclay WS. A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol 2002; 76:11744-11747.
38. Elleman CJ, Barclay WS. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 2004; 321:144-153.
39. Subbarao K, Chen H, Swayne D et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003; 305:192-200.
40. Hatta M, Kawaoka Y. The NB protein of influenza B virus is not necessary for virus replication in vitro. J Virol 2003; 77:6050-6054.
41. Crescenzo-Chaigne B, van derWerf S. Rescue of influenza C virus from recombinant DNA. J Virol 2007; 81:11282-11289.
42. Muraki Y, Murata T, Takashita E, Matsuzaki Y, Sugawara K, Hongo S. A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein. J Virol 2007; 81:8766-8773.
43. Hoffmann E, Neumann G, Hobom G, Webster RG, Kawaoka Y. "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 2000; 267:310-317.
44. Hoffmann E, Mahmood K, Yang CF, Webster RG, Greenberg HB, Kemble G. Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A 2002; 99:11411-11416.
45. Dauber B, Heins G, Wolff T. The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol 2004; 78:1865-1872.
46. Pachler K, Mayr J, Vlasak R. A seven plasmid-based system for the rescue of influenza C virus. J Mol Genet Med 2010; 4:239-246.
47. Nakowitsch S, Kittel C, Ernst W, Egorov A, Grabherr R. Optimization of baculovirus transduction on FreeStyle293 cells for the generation of influenza B/Lee/40. Mol Biotechnol 2006; 34:157-164.
48. Ozawa M, Goto H, Horimoto T, Kawaoka Y. An adenovirus vector-mediated reverse genetics system for influenza A virus generation. J Virol 2007; 81:9556-9559.
49. Neumann G, Fujii K, Kino Y, Kawaoka Y. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A 2005; 102:16825-16829.
50. World Health Organization. WHO guidance on development of influenza vaccine reference viruses by reverse genetics (WHO/CDS/CSR/GIP/2005.6). 2005. Available at http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_6.pdf. (accessed 2005).
51. Liu Q, Wang S, Ma G et al. Improved and simplified recombineering approach for influenza virus reverse genetics. J Mol Genet Med 2009; 3:225-231.
52. Wang S, Liu Q, Pu J et al. Simplified recombinational approach for influenza A virus reverse genetics. J Virol Methods 2008; 151:74-78.
53. Zhou B, Jerzak G, Scholes DT, Donnelly ME, Li Y, Wentworth DE. Reverse genetics plasmid for cloning unstable influenza A virus gene segments. J Virol Methods 2011; 173:378-383.
54. Stech J, Stech O, Herwig A et al. Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res 2008; 36:e139.
55. Wolschek M, Egorov A, Bergmann M, Muster T, Kittel C, inventors; AVIR Green Hills Biotechnology Research Development Trade AG Wien AT, assignee. Linear expression constructs for production of influenza virus particles. US Patent Application 20100129399. US. 2010.
56. Dormitzer P, Franti M, Mason P, inventors; Reverse genetics systems; International patent application WO 2011/012999. 2011.
57. Kawaoka Y, Ozawa M, inventors; National Institutes of Health (NIH) NIH division of Extramural Inventions and Technology Resources, Bethesda, MD, assignee. Adenoviral vectors for influenza virus production. US patent application 20090047728. US. 2009.
58. Conzelmann KK. Reverse genetics of mononegavirales. Curr Top Microbiol Immunol 2004; 283:1-41.
59. Roberts A, Rose JK. Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology 1998; 247:1-6.
60. Mueller S, Coleman JR, Papamichail D et al. Live attenuated influenza virus vaccines by computer-aided rational design. Nat Biotechnol 2010; 28:723-726.
61. Tumpey TM, Basler CF, Aguilar PV et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310:77-80.
62. Verity EE, Camuglia S, Agius CT et al. Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA. Influenza Other Respi Viruses 2012; 6:101-109.
63. Wimmer E, Mueller S, Tumpey TM, Taubenberger JK. Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat Biotechnol 2009; 27:1163-1172.